virucid 200mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - aciclovir - tablets - 200mg - aciclovir (0059277893) 200mg - aciclovir
zovirax 200mg/5ml oral suspension
glaxosmithkline trading services limited. (0000010863) 12 riverwalk, citywest business campus, dublin, dublin 24 - aciclovir - oral suspension - 200mg/5ml - aciclovir (0059277893) 200mg - aciclovir
mabron 100mg/2ml solution for injection or infusion
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - tramadol hydrochloride - solution for injection or infusion - 100mg/2ml - tramadol hydrochloride (0022204882) 50mg - tramadol
rofy 100mg/2ml solution for injection or infusion
codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - tramadol hydrochloride - solution for injection or infusion - 100mg/2ml - tramadol hydrochloride (0022204882) 50mg - tramadol
rofy 50mg capsule,hard
codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - tramadol hydrochloride - capsule,hard - 50mg - tramadol hydrochloride (0022204882) 50mg - tramadol
ufexil 2mg/ml solution for infusion
demo s.a. (0000003568) 21st km national road athens-lamia, krioneri, attiki, 14568 - ciprofloxacin lactate - solution for infusion - 2mg/ml - ciprofloxacin lactate (8000002398) 2,54mg - ciprofloxacin
venclyxto
abbvie deutschland gmbh co. kg - venetoclax - Λευχαιμία, λεμφοκυτταρική, χρόνια, Β-κυτταρική - Αντινεοπλασματικοί παράγοντες - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
tagrisso
astrazeneca ab - osimertinib mesilate - Καρκίνωμα, μη μικροκυτταρικός πνεύμονας - Άλλοι αντινεοπλασματικοί παράγοντες, αναστολείς πρωτεϊνικής κινάσης - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
amesol 250mg film coated tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - levofloxacin hemihydrate - film coated tablets - 250mg - levofloxacin hemihydrate (8000003372) 256mg - levofloxacin
amesol 500mg film coated tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - levofloxacin hemihydrate - film coated tablets - 500mg - levofloxacin hemihydrate (8000003372) 512mg - levofloxacin